AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + proprietary hiring database

✓Executive contact details included

INDUSTRY FIRST

Julie Gerardi Joins Parse Biosciences As Vice President of Business Development

Sep 19, 2023•almost 2 years ago

Position

Vice President of Business Development

Company

Parse Biosciences

Julie Gerardi

SeattleBiotechnology Research

Description

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Julie Gerardi has joined the company as vice president of business development. Gerardi will lead commercial strategy for large scale applications of Parse's Evercode Whole Transcriptome, Evercode TCR, and CRISPR Detect platforms in pharmaceutical drug discovery and development.

Company Information

Company

Parse Biosciences

Location

Seattle, Washington, United States

About

Parse Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available. With technology founded on the principles of SPLiT-seq, published in Science in 2018, Parse Biosciences' mission is to accelerate progress in scientific research as well as human health. Single-cell sequencing has already enabled groundbreaking discoveries that have led to new understandings in cancer treatment, tissue repair, stem cell therapy, the immune system and much more. At Parse Biosciences we provide researchers with the ability to perform single cell sequencing with unprecedented scale and ease.

Company News

(8 articles)

Tue, 04 Mar 2025 08:00:00 GMT

Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products - Business Wire

Wed, 19 Feb 2025 08:00:00 GMT

Press Release Service: Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing - CRISPR Medicine News

Mon, 11 Nov 2024 08:00:00 GMT

Comparative transcriptomic analyses of thymocytes using 10x Genomics and Parse scRNA-seq technologies - BMC Genomics

Wed, 20 Sep 2023 07:00:00 GMT

Parse Biosciences Appoints Julie Gerardi As VP - citybiz

Wed, 20 Sep 2023 16:51:34 GMT

Julie Gerardi | People on The Move - Puget Sound Business Journal - The Business Journals

Tue, 08 Jul 2025 12:35:00 GMT

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella - Kalkine Media

Tue, 07 Feb 2023 08:00:00 GMT

Parse Biosciences Announces Evercode TCR and Gene Capture - Business Wire

Tue, 04 Feb 2025 08:00:00 GMT

Press Release Service: Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products - CRISPR Medicine News

FundzWatch™ Score

Medium Activity

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months